Erik Esveld
Director/Board Member at BIOINVENT INTERNATIONAL AB
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Björn Frendéus | M | 51 | 23 years | |
Aat van Herk | M | 73 |
Van Herk Groep BV
Van Herk Groep BV Financial ConglomeratesFinance Van Herk Groep BV provides investment services to the real estate, energy, and life science sectors. The company was founded by Aat van Herk and is headquartered in Rotterdam, the Netherlands.
Van Herk Investments BV
Van Herk Investments BV Investment ManagersFinance Van Herk Investments BV (VHI) is the private equity investment arm of the Van Herk Groep BV, based in Rotterdam. The parent firm was established in the 1950s as a family business with a focus on real estate investments. VHI invests in listed and unlisted firms across diverse sectors primarily in The Netherlands. | - |
Dharminder Singh Chahal | M | 48 |
SkylineDx BV
SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands.
Van Herk Investments BV
Van Herk Investments BV Investment ManagersFinance Van Herk Investments BV (VHI) is the private equity investment arm of the Van Herk Groep BV, based in Rotterdam. The parent firm was established in the 1950s as a family business with a focus on real estate investments. VHI invests in listed and unlisted firms across diverse sectors primarily in The Netherlands. | 19 years |
Laura van't Veer | M | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | 21 years |
René Bernards | M | 72 |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 21 years |
Kurt Becker | M | 50 |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 12 years |
Arco van der Ven | M | - |
Van Herk Investments BV
Van Herk Investments BV Investment ManagersFinance Van Herk Investments BV (VHI) is the private equity investment arm of the Van Herk Groep BV, based in Rotterdam. The parent firm was established in the 1950s as a family business with a focus on real estate investments. VHI invests in listed and unlisted firms across diverse sectors primarily in The Netherlands.
Van Herk Groep BV
Van Herk Groep BV Financial ConglomeratesFinance Van Herk Groep BV provides investment services to the real estate, energy, and life science sectors. The company was founded by Aat van Herk and is headquartered in Rotterdam, the Netherlands. | 13 years |
Leonard Kruimer | M | 66 | 8 years | |
Martin Welschof | M | 63 | 6 years | |
Cecilia Hofvander | F | - | 3 years | |
Peter Michael Stein | M | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | 9 years |
Christy Garcia | F | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | 3 years |
Mark R. Straley | M | 63 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | 9 years |
François Ferré | M | 66 |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 5 years |
Stefan Ericsson | M | 61 | 26 years | |
An van Es-Johansson | M | 64 |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 5 years |
M. William Audeh | M | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | 8 years |
Vincent Ossipow | M | 55 | 8 years | |
Laurie Heilmann | F | 68 |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 5 years |
Marie Moores | F | - | 2 years | |
Jvalini Dwarkasing | M | - |
SkylineDx BV
SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | - |
Natalie Berner | F | 34 | 2 years | |
Patrick Balthrop | M | 67 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 7 years |
Stefan Glück | M | - |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | - |
Nadia Harbeck | F | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | - |
Fabrice André | M | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | - |
Ton Stam | M | - |
SkylineDx BV
SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | - |
Ingunn Munch Lindvig | M | - | 1 years | |
Stefan Sleijfer | M | - |
SkylineDx BV
SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | - |
Martin Pålsson | M | 45 | 2 years | |
Emma Meurling | F | - | - | |
Martin van Vliet | M | - |
SkylineDx BV
SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | - |
Sujatha Chandrasekaran | F | 57 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 2 years |
Sylvie Ryckebusch | M | - | 2 years | |
Kristoffer Bissessar | M | 56 | 4 years | |
Kristoffer Rudenholm Hansson | M | 50 | 8 years | |
Christoph Waer | M | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | - |
Ronald Andrews | M | 64 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 1 years |
Nanna Liebach Lüneborg | M | 49 | 2 years | |
Scott Mendel | M | 57 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 2 years |
Sirshendu Roopom Banerjee | M | 48 |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | 5 years |
Kees Sederel | M | - |
Van Herk Groep BV
Van Herk Groep BV Financial ConglomeratesFinance Van Herk Groep BV provides investment services to the real estate, energy, and life science sectors. The company was founded by Aat van Herk and is headquartered in Rotterdam, the Netherlands. | - |
Ronald van Oosten | M | - |
Van Herk Groep BV
Van Herk Groep BV Financial ConglomeratesFinance Van Herk Groep BV provides investment services to the real estate, energy, and life science sectors. The company was founded by Aat van Herk and is headquartered in Rotterdam, the Netherlands. | - |
Andres McAllister | M | 68 | 7 years | |
Thomas O. Hecht | M | 73 | 4 years | |
David Schreiber | M | 64 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 1 years |
Bernd Seizinger | M | 67 | 6 years | |
Elin Birgersson | F | 39 | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gertjan S. van der Baan | M | - |
Van Herk Investments BV
Van Herk Investments BV Investment ManagersFinance Van Herk Investments BV (VHI) is the private equity investment arm of the Van Herk Groep BV, based in Rotterdam. The parent firm was established in the 1950s as a family business with a focus on real estate investments. VHI invests in listed and unlisted firms across diverse sectors primarily in The Netherlands. | - |
Pieter Knauff | M | - |
Van Herk Investments BV
Van Herk Investments BV Investment ManagersFinance Van Herk Investments BV (VHI) is the private equity investment arm of the Van Herk Groep BV, based in Rotterdam. The parent firm was established in the 1950s as a family business with a focus on real estate investments. VHI invests in listed and unlisted firms across diverse sectors primarily in The Netherlands. | 3 years |
Edwin H. O. M. Bouwman | M | 57 |
Erasmus University Rotterdam
| 7 years |
Sebastiaan Vaessen | M | - |
Erasmus University Rotterdam
| 6 years |
Daan M. van Vlaardingen | M | - |
Erasmus University Rotterdam
| 6 years |
Boudewijn Clemens Wentink | M | 54 |
Erasmus University Rotterdam
| 4 years |
Daniel Wagener | M | - |
Erasmus University Rotterdam
| 6 years |
Bart van den Huijsen | M | - |
Erasmus University Rotterdam
| 1 years |
Andrey Burlinov | M | 52 |
Erasmus University Rotterdam
| 2 years |
Mark P. Rutten | M | 49 |
Erasmus University Rotterdam
| 1 years |
Jan-Kees de Jager | M | 55 |
Erasmus University Rotterdam
| 4 years |
Marianne Thieme | F | 52 |
Erasmus University Rotterdam
| 3 years |
Wilhelmus Simon Petrus Fortuijn | M | 76 |
Erasmus University Rotterdam
| 4 years |
Sjoerd Mostert | M | - |
Erasmus University Rotterdam
| 5 years |
Vincent van Haarlem | M | - |
Erasmus University Rotterdam
| 8 years |
Rolf Habben Jansen | M | 57 |
Erasmus University Rotterdam
| 4 years |
Arjan Lejour | M | - |
Erasmus University Rotterdam
| 1 years |
Werner Peter van Eck | M | 56 |
Erasmus University Rotterdam
| 1 years |
Mariken Tannemaat | F | 52 |
Erasmus University Rotterdam
| 2 years |
Pram Kurniawan | M | - |
Erasmus University Rotterdam
| 2 years |
Maarten Holtslag | M | - |
Nyenrode Business Universiteit
| 1 years |
Victor Van Eijk | M | - |
Erasmus University Rotterdam
| 15 years |
Roland Toppen | M | - |
Erasmus University Rotterdam
| 6 years |
Leo Evers | M | 59 |
Erasmus University Rotterdam
| 2 years |
Gideon Tilburgs | M | - |
Erasmus University Rotterdam
| 8 years |
Jeroen Nathal | M | - |
Erasmus University Rotterdam
| 5 years |
Hans van Seters | M | - |
Erasmus University Rotterdam
| 6 years |
Johannes Hermanus de Wit | M | 62 |
Erasmus University Rotterdam
| 2 years |
Hendrik-Jan Stoker | M | - |
Erasmus University Rotterdam
| 3 years |
Dimitri Willems | M | - |
Erasmus University Rotterdam
| 4 years |
Alexander Hendrik Rinnooy Kan | M | 74 |
Erasmus University Rotterdam
| 14 years |
Maarten Hendrik Wildschut | M | - |
Erasmus University Rotterdam
| 6 years |
Ruulke Bagijn | F | - |
Erasmus University Rotterdam
| 3 years |
George Westerkamp | M | - |
Erasmus University Rotterdam
| 5 years |
Maarten Friederich | M | - |
Erasmus University Rotterdam
| 4 years |
Mark Wegter | M | 54 |
Erasmus University Rotterdam
| 1 years |
Ewout Prins | M | 51 |
Erasmus University Rotterdam
| 6 years |
Paul Lageweg | M | 54 |
Erasmus University Rotterdam
| 6 years |
Maaike van der Schoot | F | - |
Erasmus University Rotterdam
| 6 years |
Sander van Vreumingen | M | 48 |
Erasmus University Rotterdam
| 7 years |
Johan Henrik Andresen | M | 63 |
Erasmus University Rotterdam
| 2 years |
Peter Paul F. de Vries | M | 57 |
Erasmus University Rotterdam
| 6 years |
Marjan Johanna Oudeman | F | 65 |
Erasmus University Rotterdam
| 2 years |
Erik M. van Mulligen | M | - |
Erasmus University Rotterdam
| 3 years |
Paul J. Vrancken | M | - |
Erasmus University Rotterdam
| 5 years |
Henry Makansi | M | - |
Erasmus University Rotterdam
| 5 years |
Rene M. Lipsch | M | - |
Erasmus University Rotterdam
| 6 years |
Stefan den Doelder | M | - |
Erasmus University Rotterdam
| 6 years |
Mark Jans | M | 54 |
Erasmus University Rotterdam
| 4 years |
Jeroen J. M. Kremers | M | 66 |
Erasmus University Rotterdam
| 12 years |
Geert-Jan Schipper | M | 59 |
Erasmus University Rotterdam
| 4 years |
Stephan Koen | M | - |
Erasmus University Rotterdam
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
Netherlands | 73 | 73.00% |
Sweden | 20 | 20.00% |
United States | 18 | 18.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Erik Esveld
- Personal Network